NH2-C5-NH-Boc
CAS No. 51644-96-3
NH2-C5-NH-Boc( PROTAC Linker 23 )
Catalog No. M27008 CAS No. 51644-96-3
NH2-C5-NH-Boc (PROTAC Linker 23) is an alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 500MG | 30 | In Stock |
|
| 1G | 38 | In Stock |
|
Biological Information
-
Product NameNH2-C5-NH-Boc
-
NoteResearch use only, not for human use.
-
Brief DescriptionNH2-C5-NH-Boc (PROTAC Linker 23) is an alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs.
-
DescriptionNH2-C5-NH-Boc (PROTAC Linker 23) is an alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs.
-
In VitroPROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins.
-
In Vivo——
-
SynonymsPROTAC Linker 23
-
PathwayOthers
-
TargetOther Targets
-
RecptorApoptosis
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number51644-96-3
-
Formula Weight202.298
-
Molecular FormulaC10H22N2O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?Ethanol : 100 mg/mL (494.34 m)
-
SMILESCC(C)(C)OC(=O)NCCCCCN
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Schumacher MM, et al. The prenyltransferase UBIAD1 is the target of geranylgeraniol in degradation of HMG CoA reductase. Elife. 2015 Mar 5;4.
molnova catalog
related products
-
Glucolimnanthin
Glucolimnanthin is a natural product for research related to life sciences.
-
N-(2-Chloro-6-methyl...
N-(2-Chloro-6-methylphenyl)-N'-4-pyridinylurea is an anticonvulsant agent, treatment of generalized tonic-clonic and partial seizures.
-
Frovocimab
Frovocimab (LY 3015014) is a humanized IgG4 monoclonal antibody to Subtilisin/Kexin Protein Converting Enzyme Type 9 (PCSK9) that binds to the catalytic domain of PCSK9 and lowers low-density lipoprotein cholesterol (LDL-C) in patients with hypercholesterolemia.Frovocimab is used in the study of hypercholesterolemia.
Cart
sales@molnova.com